The INVESTOR Selection committee is responsible for the quality of the selected startups. Candidates will be evaluated based on specific selection criteria.
The selection committee will be present during the event to evaluate the pitching candidates and select the award winners.
The 2017 BIOVISION Investor Selection Committee is co-chaired by Laurence Bougnères-Vermont, Investment director at Auriga Partners and Christophe Van Vaeck, Principal at GIMV.
The selection committee will be completed by members of Alstin, Abingworth, Advent LS, Aravis Fund, Auriga Partners, Bpifrance, Capricorn, CM-CIC Capital Innovation, Crédit Agricole Création, EMBL, Emertec, Forbion, GIMV, IndexVentures, Kurma life Sciences Partners, LyonBiopole, Merieux Developpement, Novartis VF, Omnès Capital, Panakes, Seb Alliance, Seventure, Société Générale, Sofinnova Partners, Syncona Partners, TVM Capital, and Vesalius.